Healthcare Industry News & Updates

Regulatory changes (FDA, CDSCO, etc.), pharma industry news, healthcare policy updates.

Liver Disease Risk

The Hidden Genetic Mutation Putting East Asians at Higher Liver Disease Risk

Researchers from Osaka Metropolitan University have uncovered a critical mechanism linking a common genetic mutation to liver damage, coining the term “aldehyde storm.” Their findings not only highlight the biological pathways behind liver disease but also offer practical lifestyle advice to reduce risks. 🧬 The Role of ALDH2: Your Body’s Detox Enzyme The enzyme Aldehyde […]

The Hidden Genetic Mutation Putting East Asians at Higher Liver Disease Risk Read More »

Detailed 3D representation of the coronavirus structure highlighting spike proteins.

Nipah Virus Alert: Kerala on High Surveillance

Kerala is once again in the news, as the Nipah virus has recently been identified in Palakkad of Kerala, where the state health department has already imposed measures against the situation and containment measures. Because of its extremely high rate of fatality and its previous episodes of leading to the death of several individuals, the

Nipah Virus Alert: Kerala on High Surveillance Read More »

Scientist in a lab coat using a microscope to conduct research, focusing on healthcare improvements.

Corona Re-entry in India: A Wake-Up Call or Just a Ripple?

As the global community begins to recover from the severe impacts of the COVID-19 pandemic, India is once again confronted with the resurgence of the coronavirus. Although this development may incite concern, experts advocate for a response characterised by calmness and informed decision-making rather than fear. Therefore, it is imperative to understand the implications of

Corona Re-entry in India: A Wake-Up Call or Just a Ripple? Read More »

Close-up of an employee sorting documents with sticky notes and pens on a wooden desk.

Understanding CDSCO Guidelines for Pharmaceutical Submissions

The Central Drugs Standard Control Organization (CDSCO) is instrumental in regulating the approval of pharmaceutical products in India. As the national regulatory authority, its decisions significantly influence the direction of both clinical research and pharmaceutical innovation. For researchers, manufacturers, and regulatory professionals, a comprehensive understanding of CDSCO’s requirements is imperative. The pharmaceutical submission process involves

Understanding CDSCO Guidelines for Pharmaceutical Submissions Read More »